|
WO1984003506A1
(en)
|
1983-03-08 |
1984-09-13 |
Commw Serum Lab Commission |
Antigenically active amino acid sequences
|
|
NZ207394A
(en)
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
|
JPS60500673A
(ja)
|
1983-03-08 |
1985-05-09 |
コモンウエルス セラム ラボラトリ−ズ コミツシヨン |
抗原活性を有するアミノ酸配列
|
|
US4863940A
(en)
|
1984-07-26 |
1989-09-05 |
Rohm And Haas |
N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5571689A
(en)
|
1988-06-16 |
1996-11-05 |
Washington University |
Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
WO1990007329A1
(en)
|
1989-01-06 |
1990-07-12 |
The Regents Of The University Of California |
Selection method for pharmacologically active compounds
|
|
IE910847A1
(en)
|
1990-03-13 |
1991-09-25 |
Fisons Plc |
Immunosuppressive macrocyclic compounds
|
|
DE69130831T2
(de)
|
1990-11-21 |
1999-09-16 |
Iterex Pharmaceuticals Ltd. Partnership, San Diego |
Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1992013549A1
(en)
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
SE9102462D0
(sv)
|
1991-08-28 |
1991-08-28 |
Astra Ab |
New isosteric peptides
|
|
EP0541946B1
(de)
|
1991-10-07 |
1996-07-17 |
Hoechst Aktiengesellschaft |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
CA2138124A1
(en)
|
1992-06-24 |
1994-01-06 |
David D. Eveleth, Jr. |
Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
|
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
|
WO1995009859A1
(en)
|
1993-10-07 |
1995-04-13 |
The Du Pont Merck Pharmaceutical Company |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
|
ATE377006T1
(de)
|
1995-11-28 |
2007-11-15 |
Cephalon Inc |
Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
|
|
DE19642591A1
(de)
|
1996-10-15 |
1998-04-16 |
Basf Ag |
Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
|
|
JP2002514192A
(ja)
|
1996-11-13 |
2002-05-14 |
セフアロン・インコーポレーテツド |
ベンゾチアゾおよび関連の複素環基を含有するシステインおよびセリンプロテアーゼ阻害剤
|
|
DE19648793A1
(de)
|
1996-11-26 |
1998-05-28 |
Basf Ag |
Neue Benzamide und deren Anwendung
|
|
US5952322A
(en)
|
1996-12-05 |
1999-09-14 |
Pfizer Inc. |
Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
|
|
DE19650975A1
(de)
|
1996-12-09 |
1998-06-10 |
Basf Ag |
Neue heterocyclisch substituierte Benzamide und deren Anwendung
|
|
SK282680B6
(sk)
|
1996-12-11 |
2002-11-06 |
Basf Aktiengesellschaft |
Ketobenzamidy, farmaceutické prípravky s ich obsahom a ich použitie na potlačenie chorôb
|
|
DE69826881T2
(de)
|
1997-03-14 |
2005-12-01 |
Smithkline Beecham Corp. |
Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
|
|
DE69824582T2
(de)
*
|
1997-03-14 |
2005-07-07 |
Smithkline Beecham Corp. |
Neuartige Chinolin- und Naphthalincarboxamide, pharmazeutische Zusammensetzungen und Verfahren zum Inhibieren von Calpain
|
|
US6083944A
(en)
|
1997-10-07 |
2000-07-04 |
Cephalon, Inc. |
Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6150378A
(en)
|
1997-10-07 |
2000-11-21 |
Cephalon, Inc. |
Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
WO1999050264A1
(en)
|
1998-03-30 |
1999-10-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Quinazoline derivatives
|
|
KR20010042839A
(ko)
|
1998-04-20 |
2001-05-25 |
스타르크, 카르크 |
시스테인 프로테아제를 억제하는 효과를 나타내고헤테로시클릭 치환체가 있는 신규 아미드
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
AU3927699A
(en)
|
1998-04-20 |
1999-11-08 |
Basf Aktiengesellschaft |
New substituted amides, their production and their use
|
|
DE19818614A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Amide, deren Herstellung und Anwendung
|
|
EP1082308B1
(de)
|
1998-04-20 |
2009-04-01 |
Abbott GmbH & Co. KG |
Heterocyclisch substituierte amide als calpainhemmer
|
|
DE19817459A1
(de)
*
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue heterozyklische substituierte Amide, Herstellung und Anwendung
|
|
US6482832B1
(en)
|
1998-05-25 |
2002-11-19 |
Abbott Laboratories |
Heterocyclically substituted amides, their production and their use
|
|
US6335155B1
(en)
|
1998-06-26 |
2002-01-01 |
Sunesis Pharmaceuticals, Inc. |
Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
|
|
US6280946B2
(en)
|
1998-08-07 |
2001-08-28 |
Boston Probes, Inc. |
PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
|
|
WO2000039585A1
(en)
|
1998-12-28 |
2000-07-06 |
Sunesis Pharmaceuticals, Inc. |
Identifying small organic molecule ligands for binding
|
|
EP1159260A1
(en)
|
1999-03-15 |
2001-12-05 |
Axys Pharmaceuticals, Inc. |
Novel compounds and compositions as protease inhibitors
|
|
ES2215626T3
(es)
*
|
1999-03-15 |
2004-10-16 |
Axys Pharmaceuticals, Inc. |
N-cianomethil amidas como inhibidores de proteasas.
|
|
EP1165490B1
(en)
|
1999-03-16 |
2006-08-16 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
DE50010931D1
(de)
|
1999-06-23 |
2005-09-15 |
Aventis Pharma Gmbh |
Substituierte benzimidazole
|
|
KR20020067702A
(ko)
|
2000-01-26 |
2002-08-23 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 5원환 화합물 및 이러한 화합물을 유효성분으로서 함유하는 약제
|
|
EP1283728A2
(en)
|
2000-05-23 |
2003-02-19 |
Amersham Health AS |
Contrast agents
|
|
US6582827B1
(en)
|
2000-11-27 |
2003-06-24 |
The Trustees Of Columbia University In The City Of New York |
Specialized substrates for use in sequential lateral solidification processing
|
|
DE10114762A1
(de)
|
2001-03-26 |
2002-10-02 |
Knoll Gmbh |
Verwendung von Cysteinprotease-Inhibitoren
|
|
PT2280070E
(pt)
|
2001-07-23 |
2015-10-29 |
Univ Leland Stanford Junior |
Métodos e composições para inibição mediada por iarn da expressão génica em mamíferos
|
|
WO2003024955A2
(en)
|
2001-09-18 |
2003-03-27 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
US20030167490A1
(en)
|
2001-11-26 |
2003-09-04 |
Hunter Craig P. |
Gene silencing by systemic RNA interference
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
PL369772A1
(en)
|
2002-01-31 |
2005-05-02 |
Morphochem Aktiengesellschaft Für Kombinatorischechemie |
Compounds that inhibit factor xa activity
|
|
WO2003091202A1
(en)
|
2002-04-25 |
2003-11-06 |
Ono Pharmaceutical Co., Ltd. |
Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
|
|
CA2493008A1
(en)
|
2002-08-09 |
2004-02-19 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
|
AU2004204760C1
(en)
|
2003-01-08 |
2010-08-19 |
Novartis Vaccines And Diagnostics, Inc. |
Antibacterial agents
|
|
US20040242542A1
(en)
|
2003-03-25 |
2004-12-02 |
The Regents Of The University Of California |
Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders
|
|
WO2005000793A1
(ja)
|
2003-06-26 |
2005-01-06 |
Taisho Pharmaceutical Co., Ltd. |
２位置換シクロアルキルカルボン酸誘導体
|
|
EP1493739A1
(fr)
|
2003-07-03 |
2005-01-05 |
Warner-Lambert Company LLC |
Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
CN100406016C
(zh)
|
2003-07-21 |
2008-07-30 |
诺瓦提斯公司 |
用于治疗骨转移瘤、肿瘤生长和肿瘤诱导的骨丢失的组织蛋白酶k抑制剂和二膦酸盐/酯的组合
|
|
US7459472B2
(en)
|
2003-08-08 |
2008-12-02 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
CN1835936A
(zh)
|
2003-08-14 |
2006-09-20 |
默克公司 |
用于治疗阿尔茨海默氏病的大环β－分泌酶抑制剂
|
|
JPWO2005102381A1
(ja)
|
2004-04-26 |
2008-03-06 |
小野薬品工業株式会社 |
カテプシンｋ阻害薬およびｐｔｈ類を併用することを特徴とする骨密度増加剤
|
|
RU2007119427A
(ru)
|
2004-11-09 |
2008-12-20 |
СмитКлайн Бичем Корпорейшн (US) |
Соединения, являющиеся ингибиторами гликогенфосфорилазы, и фармацевтические композиции на их основе
|
|
US8257931B2
(en)
|
2005-01-21 |
2012-09-04 |
President And Fellows Of Harvard College |
Regulation of protein synthesis
|
|
US20080311036A1
(en)
*
|
2005-05-11 |
2008-12-18 |
University Of Florida Research Foundation, Inc. |
Imaging of Neural and Organ Injury or Damage
|
|
WO2007016476A2
(en)
|
2005-08-01 |
2007-02-08 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
EP1968568A4
(en)
|
2005-12-22 |
2011-04-13 |
Glaxosmithkline Llc |
HEMMER OF NUTS ACTIVITY
|
|
WO2007081530A2
(en)
|
2006-01-03 |
2007-07-19 |
Med Institute, Inc. |
Endoluminal medical device for local delivery of cathepsin inhibitors
|
|
US20090304631A1
(en)
|
2006-01-27 |
2009-12-10 |
David Alan Campbell |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US20070207144A1
(en)
|
2006-02-16 |
2007-09-06 |
Lee Rubin |
Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
|
|
NZ571280A
(en)
|
2006-03-16 |
2011-10-28 |
Vertex Pharma |
Deuterated hepatitis C protease inhibitors
|
|
US20080045521A1
(en)
|
2006-06-09 |
2008-02-21 |
Astrazeneca Ab |
Phenylalanine derivatives
|
|
US8710178B2
(en)
|
2006-10-18 |
2014-04-29 |
Lincoln University |
Macrocyclic cysteine protease inhibitors and compositions thereof
|
|
KR101578674B1
(ko)
|
2006-12-29 |
2015-12-18 |
아비에 도이치란트 게엠베하 운트 콤파니 카게 |
카복스아미드 화합물 및 칼페인 억제제로서의 이의 용도
|
|
EP2134717A2
(en)
|
2007-02-27 |
2009-12-23 |
Vertex Pharmceuticals Incorporated |
Inhibitors of serine proteases
|
|
CN107021895A
(zh)
|
2007-06-12 |
2017-08-08 |
尔察祯有限公司 |
抗菌剂
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
TWI453019B
(zh)
|
2007-12-28 |
2014-09-21 |
Abbvie Deutschland |
甲醯胺化合物
|
|
WO2010023609A1
(en)
|
2008-08-25 |
2010-03-04 |
Piramal Life Sciences Limited |
Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors
|
|
JP5583694B2
(ja)
|
2009-01-05 |
2014-09-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体を調節するピロリジン化合物
|
|
GB2467561A
(en)
|
2009-02-06 |
2010-08-11 |
Summit Corp Plc |
Dual calpain-ROS inhibitors
|
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
|
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
|
US9051304B2
(en)
|
2009-12-22 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
US8598211B2
(en)
|
2009-12-22 |
2013-12-03 |
Abbvie Inc. |
Carboxamide compounds and their use as calpain inhibitors IV
|
|
TW201134825A
(en)
|
2009-12-30 |
2011-10-16 |
Avila Therapeutics Inc |
Ligand-directed covalent modification of protein
|
|
WO2011133346A1
(en)
|
2010-04-21 |
2011-10-27 |
Pharmacofore, Inc. |
Peripheral opioid agonists and peripheral opioid antagonists
|
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
|
WO2011159781A2
(en)
|
2010-06-17 |
2011-12-22 |
Senomyx, Inc. |
Bitter taste modulators
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012021788A2
(en)
|
2010-08-13 |
2012-02-16 |
Banyan Biomarkers |
Dipeptide calpain inhibitors
|
|
CN103201262B
(zh)
|
2010-08-20 |
2016-06-01 |
艾米拉医药股份有限公司 |
自分泌运动因子抑制剂及其用途
|
|
WO2012040242A1
(en)
|
2010-09-22 |
2012-03-29 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
|
CA2819087A1
(en)
|
2010-12-09 |
2012-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors v
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
BR112013022946A2
(pt)
|
2011-03-09 |
2017-07-18 |
Signature Therapeutics Inc |
pró-fármacos de agentes ativos com ligantes heterocíclocos
|
|
CA2833082C
(en)
|
2011-04-15 |
2019-12-31 |
New World Laboratories, Inc. |
Selective cysteine protease inhibitors and uses thereof
|
|
ES2929179T3
(es)
|
2011-08-30 |
2022-11-25 |
Tufts College |
Inhibidores del proteasoma activados por FAP para el tratamiento de tumores sólidos
|
|
KR20140102253A
(ko)
|
2011-11-25 |
2014-08-21 |
에프. 호프만-라 로슈 아게 |
카텝신의 억제제로서의 피롤리딘 유도체
|
|
MX352654B
(es)
|
2012-01-11 |
2017-12-04 |
Hoffmann La Roche |
Amidas macrociclicas como inhibidores de proteasas.
|
|
RU2014144285A
(ru)
|
2012-04-03 |
2016-05-27 |
Эббви Дойчланд Гмбх Унд Ко. Кг |
Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина v
|
|
US9309284B2
(en)
|
2012-05-02 |
2016-04-12 |
Kansas State University Reasearch Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
|
|
JP2016501848A
(ja)
|
2012-11-16 |
2016-01-21 |
アデレード リサーチ アンド イノヴェーション プロプライエタリー リミテッド |
大環状化合物及びその使用
|
|
CN105492444B
(zh)
|
2013-07-02 |
2018-09-07 |
百时美施贵宝公司 |
作为rock抑制剂的三环吡啶-甲酰胺衍生物
|
|
UY35834A
(es)
|
2013-11-14 |
2015-05-29 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
|
|
EP3107952B1
(en)
|
2014-02-19 |
2018-09-26 |
ETH Zurich |
Method for the generation of chemical libraries
|
|
WO2015140199A1
(de)
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
US10392422B2
(en)
|
2014-05-20 |
2019-08-27 |
Rqx Pharmaceuticals, Inc. |
Macrocyclic broad spectrum antibiotics
|
|
WO2015196086A1
(en)
*
|
2014-06-20 |
2015-12-23 |
The University of Montana, Missoula, MT |
NOVEL INHIBITORS OF SYSTEM Xc(-)
|
|
WO2016027284A2
(en)
|
2014-08-22 |
2016-02-25 |
Alkem Laboratories Ltd. |
Piperidine ureas as cathepsin cysteine protease inhibitors
|
|
EP3189047B1
(en)
|
2014-09-04 |
2018-12-26 |
Bristol-Myers Squibb Company |
Diamide macrocycles that are fxia inhibitors
|
|
US11219670B2
(en)
|
2014-09-05 |
2022-01-11 |
The Johns Hopkins University |
Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
RU2732405C2
(ru)
|
2015-07-02 |
2020-09-16 |
Тёрнинг Поинт Терапьютикс, Инк. |
Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ
|
|
MX2018006856A
(es)
|
2015-12-07 |
2018-08-01 |
Plexxikon Inc |
Compuestos y metodos para modulacion de la quinasa, e indicaciones de los mismos.
|
|
CN105669520B
(zh)
|
2016-01-12 |
2018-10-30 |
山东大学 |
含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
AU2017229591B2
(en)
|
2016-03-09 |
2021-08-19 |
Blade Therapeutics Pty Ltd |
Calpain modulators and methods of production and use thereof
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
US11560356B2
(en)
|
2016-06-29 |
2023-01-24 |
The Regents Of The University Of California |
Compounds and compositions for the treatment of cancer
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
SG10201912574WA
(en)
|
2016-09-28 |
2020-02-27 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
|
AU2018289434A1
(en)
|
2017-06-23 |
2020-01-16 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
SG11202008773PA
(en)
|
2018-03-28 |
2020-10-29 |
Blade Therapeutics Inc |
Method of treating fibrotic disease
|
|
CA3095164A1
(en)
|
2018-03-28 |
2019-10-03 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US20210253642A1
(en)
|
2018-05-09 |
2021-08-19 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof background
|
|
MX2021000154A
(es)
|
2018-06-28 |
2021-04-19 |
Blade Therapeutics Inc |
Metodos de tratamiento de fibrosis hepatica que usan inhibidores de calpaina.
|
|
WO2020006177A1
(en)
|
2018-06-29 |
2020-01-02 |
Blade Therapeutics, Inc. |
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|